Ultragenyx Pharmaceutical | Rentekostnader



Interest Expense On Debt Endring Dato
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Insmed USD 19.8M 532K 2024-12
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
Kyowa Hakko Kirin 5.64B 4.66B 2024-12
MacroGenics USD -24000 24K 2024-12
Moderna USD 1000K 5M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Sarepta Therapeutics USD 4.92M 86K 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Ultragenyx Pharmaceutical Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.